Jamie Clark
Stock Analyst at Rothschild & Co
(2.74)
# 1,822
Out of 5,130 analysts
9
Total ratings
85.71%
Success rate
16.34%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Jamie Clark
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| WST West Pharmaceutical Services | Initiates: Buy | $311 | $275.52 | +12.88% | 1 | Sep 15, 2025 | |
| MEDP Medpace Holdings | Downgrades: Neutral | $342 → $474 | $595.00 | -20.34% | 1 | Sep 3, 2025 | |
| ICLR ICON Public Limited Company | Upgrades: Buy | $184 → $236 | $181.38 | +30.11% | 1 | Sep 3, 2025 | |
| CRL Charles River Laboratories International | Upgrades: Buy | $188 → $182 | $220.91 | -17.61% | 3 | May 23, 2025 | |
| LH Labcorp Holdings | Initiates: Buy | $276 | $251.81 | +9.61% | 1 | Apr 2, 2025 | |
| DGX Quest Diagnostics | Initiates: Buy | $195 | $174.44 | +11.79% | 1 | Apr 2, 2025 | |
| IQV IQVIA Holdings | Initiates: Buy | $276 | $242.41 | +13.86% | 1 | Oct 14, 2024 |
West Pharmaceutical Services
Sep 15, 2025
Initiates: Buy
Price Target: $311
Current: $275.52
Upside: +12.88%
Medpace Holdings
Sep 3, 2025
Downgrades: Neutral
Price Target: $342 → $474
Current: $595.00
Upside: -20.34%
ICON Public Limited Company
Sep 3, 2025
Upgrades: Buy
Price Target: $184 → $236
Current: $181.38
Upside: +30.11%
Charles River Laboratories International
May 23, 2025
Upgrades: Buy
Price Target: $188 → $182
Current: $220.91
Upside: -17.61%
Labcorp Holdings
Apr 2, 2025
Initiates: Buy
Price Target: $276
Current: $251.81
Upside: +9.61%
Quest Diagnostics
Apr 2, 2025
Initiates: Buy
Price Target: $195
Current: $174.44
Upside: +11.79%
IQVIA Holdings
Oct 14, 2024
Initiates: Buy
Price Target: $276
Current: $242.41
Upside: +13.86%